Free Trial

Pasithea Therapeutics (KTTAW) Competitors

$0.02 0.00 (0.00%)
As of 08/22/2025

KTTAW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Pasithea Therapeutics stock or one of its competitors? The main competitors of Pasithea Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Pasithea Therapeutics vs. Its Competitors

Pasithea Therapeutics (NASDAQ:KTTAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

In the previous week, Pasithea Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Pasithea Therapeutics Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Pasithea TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pasithea TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Pasithea Therapeutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Pasithea Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KTTAW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KTTAW vs. The Competition

MetricPasithea TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.14M$5.83B$9.74B
Dividend YieldN/A3.74%4.40%4.10%
P/E RatioN/A3.8731.4326.05
Price / SalesN/A4,053.60469.65121.10
Price / CashN/A13.1925.7828.78
Price / BookN/A47.039.526.07
Net IncomeN/A-$90.99M$3.26B$265.39M
7 Day PerformanceN/A0.19%1.37%1.56%
1 Month PerformanceN/A1.90%2.97%0.48%
1 Year PerformanceN/A203.46%30.23%18.88%

Pasithea Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KTTAW
Pasithea Therapeutics
N/A$0.02
flat
N/AN/A$0.00N/A0.003
ATNFW
180 Life Sciences
N/A$0.20
-25.7%
N/A+2,400.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.46
+2.4%
N/AN/A$0.00$110.87K0.0040Gap Up
ALVOW
Alvotech
N/A$1.18
+4.3%
N/A-60.7%$0.00$560.10M0.004Positive News
Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
-30.5%
N/A-37.3%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-0.1%
N/A+176.6%$0.00$39.19M0.0070Positive News
BTMDW
biote
N/A$0.01
+0.9%
N/A-95.5%$0.00$199.07M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.02
+18.4%
N/A-92.1%$0.00N/A0.008Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:KTTAW) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners